X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

ONCOGENE

期刊標題檢索 ONCOGENE 最新評論: It has been 100 days since the first review, and I'm done. Currently... (2025-10-17)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[ONCOGENE]您好,您是該頁面的第 267553 位訪客。

期刊簡介
期刊名稱ONCOGENE ONCOGENE
LetPub Score
9.0
51 ratings
Rate

Reputation
9.7

Influence
8.5

Speed
8.3

期刊簡稱ONCOGENE
ISSN0950-9232
E-ISSN1476-5594
h-index312
CiteScore
CiteScoreSJRSNIPCiteScore Rank
15.402.4891.455
Subject fieldQuartilesRankPercentile
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Genetics
Q116 / 348
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Molecular Biology
Q134 / 410
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Cancer Research
Q125 / 233

自引率 (2023-2024)1.40%自引率趨勢
掲載範囲
Oncogene aims to make substantial advances in our knowledge of processes that contribute to cancer by publishing outstanding research. We propagate work that challenges standard conjecture and builds on previous studies, in particular those that lead to establishing new paradigms in the etio-pathogenesis, diagnosis, treatment, or prevention of cancers, and in processes that drive metastatic spread, and provide important insights into cancer biology beyond what has been revealed thus far.
官方網站https://www.nature.com/onc
在線稿件提交https://mts-onc.nature.com/
開放訪問No
出版商Springer Nature
主題領域医学
出版國/地區ENGLAND
發行頻率週刊
創刊年1997
每年文章數287每年文章數趨勢
黃金OA百分比38.62%
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
BIOCHEMISTRY & MOLECULAR BIOLOGYSCIEQ139/320
CELL BIOLOGYSCIEQ139/204
GENETICS & HEREDITYSCIEQ116/192
ONCOLOGYSCIEQ143/328
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0950-9232%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: About 1.0 month(s)
競爭力 *來自作者的數據: About 31.25%
參考鏈接
相關期刊 【ONCOGENE】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    NATURE MEDICINEH-index: 497

    CiteScore: 82.40
    CELLH-index: 705

    CiteScore: 74.80
    Molecular CancerH-index: 103

    CiteScore: 47.40
    Molecular PlantH-index: 85

    CiteScore: 28.20
    NUCLEIC ACIDS RESEARCHH-index: 452

    CiteScore: 31.70
    Molecular CellH-index: 356

    CiteScore: 24.40
    PROGRESS IN LIPID RESEARCHH-index: 132

    CiteScore: 29.90
    TRENDS IN MICROBIOLOGYH-index: 172

    CiteScore: 25.80
    CELL DEATH AND DIFFERENTIATIONH-index: 193

    CiteScore: 29.00
    Nature Chemical BiologyH-index: 182

    CiteScore: 21.50
    學科內最受檢索的期刊 頁面查看次數
    International Journal of Biological Macromolecules2057383
    CELL BIOCHEMISTRY AND BIOPHYSICS1220795
    FASEB JOURNAL796621
    NUCLEIC ACIDS RESEARCH730539
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS712789
    Molecular Cancer411304
    JOURNAL OF BIOLOGICAL CHEMISTRY404960
    GENETICS AND MOLECULAR RESEARCH345752
    International Journal of Biological Sciences345050
    CELL321724
  •  

    ONCOGENE ONCOGENE
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/30)
  [ONCOGENE] 的評論撰寫評論
作者: zzzmianyi


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-14 20:42:34 評論於
Submitted in September 23rd, received first round of comments in early December asking for additional experiments, submitted in February, received second round of comments twenty days later asking for further experiments, just resubmitted in April, not sure about the outcome
(1) 讚! | zzzmianyi

作者: 春海小公主


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-13 20:44:36 評論於
Does "QC started" refer to internal audit in the editing department? Is it possible that it's still with the editor?
(0) 讚! | 春海小公主

作者: 岭南芮静


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-14 19:26:04 評論於
How did it go?
(0) 讚! | 岭南芮静

作者: 一条小秋华


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-07 18:54:54 評論於
Why does the editorial department still require non-OA selections to pay publication fees? Have they all refused to publish without payment?
(0) 讚! | 一条小秋华

作者: Zona Patrick


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-31 22:06:14 評論於
Please translate the following passage into English and Japanese, and title them ":" and ":"
(0) 讚! | Zona Patrick

作者: 薪羽超级甜


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-31 08:43:22 評論於
I have been waiting for 16 days, and it's still like this
(0) 讚! | 薪羽超级甜

作者: 素香少爷


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-30 15:58:53 評論於
May I ask how many Reviewers you have?
(0) 讚! | 素香少爷

作者: 华清彤雯


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-25 21:55:17 評論於
Seeking submissions status
(0) 讚! | 华清彤雯

作者: 华清彤雯


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-25 18:43:46 評論於
How long have we been waiting at this step?
(0) 讚! | 华清彤雯

作者: 薪羽超级甜


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-24 23:21:51 評論於
Can you share the status of the submission?
(0) 讚! | 薪羽超级甜

作者: 一条小秋华


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-19 09:56:14 評論於
Emphasis on Research Field: molecular oncology; cancer; Molecular cancer
Experience Sharing: Submitted in July 2023, received first round of comments in November 2023, minor revisions were given one month to complete and returned by the end of the month, tentatively accepted in January, accepted after making some minor changes, went online ten days later
(0) 讚! | 一条小秋华

作者: 香凝可爱吗


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-14 13:26:34 評論於
How long have we been waiting for this step?
(0) 讚! | 香凝可爱吗

作者: 蓉沼芳洲


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-08 17:25:45 評論於
How have you been, my friend?
(0) 讚! | 蓉沼芳洲

作者: 华清彤雯


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-26 19:21:54 評論於
How long have you been waiting here?
(0) 讚! | 华清彤雯

作者: 蓉沼芳洲


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-15 16:55:39 評論於
How long does it take to get feedback?
(0) 讚! | 蓉沼芳洲

作者: Zona Patrick


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-13 08:30:04 評論於
The decision letter is usually received the next day
(0) 讚! | Zona Patrick

作者: 极乐从雪


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-12 22:21:03 評論於
Oh, we are exactly the same. How have you been since then?
(0) 讚! | 极乐从雪

作者: Zona Patrick


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-12 18:17:06 評論於
Have you received it now? Good luck!
(0) 讚! | Zona Patrick

作者: Zona Patrick


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-07 19:41:40 評論於
"Please translate the following paragraph into English and Japanese. 

只限6个哦"
(0) 讚! | Zona Patrick

作者: Bernie David


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-05 20:48:13 評論於
It's really troublesome
(0) 讚! | Bernie David

作者: Zona Patrick


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-04 11:52:18 評論於
Is it showing "Waiting for Revision"?
(0) 讚! | Zona Patrick

作者: Bernie David


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-27 13:33:17 評論於
After one month of external audit, the current status is decision made. It has been two or three days, and I still haven't received any email. There has been no visible change in the system. Does this mean I have been rejected?
(0) 讚! | Bernie David

作者: Zona Patrick


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-15 14:51:40 評論於
Just fixed it
(0) 讚! | Zona Patrick

作者: 铁头紫柔


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-07 23:38:50 評論於
Please translate the following paragraph into English and Japanese and title them respectively as ":" and ":"
(0) 讚! | 铁头紫柔

作者: 铁头紫柔


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-07 09:31:44 評論於
How are things going now?
(0) 讚! | 铁头紫柔

首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/30)

開始撰寫 [ONCOGENE] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*